PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and branded by Greenville (“bbG”), is excited to announce the official start of an extensive rebranding campaign to renew its corporate vision. This rebranding initiative aims to strengthen the Company’s identity and culture in the market and to better reflect its commitment to cutting-edge scientific advancements in antimicrobials and disinfection to serve the food and beverage industry.

This rebranding initiative comes at a pivotal time for PURE, as the company continues to expand its product offerings and enhance its commitment to providing safer, effective solutions across various industries. The refreshed brand identity is designed to resonate with existing customers and new audiences, emphasizing PURE’s mission of delivering a new generation of effective and powerful cleaning and disinfection solutions.

“We are thrilled to unveil our new brand identity, which embodies the dynamic spirit of the Company,” said Robert Bartlett, Chief Executive Officer at PURE. “As we continue to innovate and push boundaries in the food and beverage industry, our new branding will help us communicate our vision more effectively to our stakeholders.”

bbG, a full-service design agency known for its creative strategies and impactful branding solutions, spearheaded the rebranding project. bbG played a crucial role in developing a cohesive visual identity and messaging framework that aligns with PURE’s long-term goals.

“Working with PURE has been an inspiring experience,” said Evan Barnes, founder of bbG. “PURE’s dedication to innovation and sustainability guided our creative process. We believe the new brand identity reflects the Company’s values and positions them strongly for future growth in their market space.”

Initial Brand Elements

The new logo represents the company, its people, and its brand. It combines a sleek minimalist wordmark with a molecular-inspired icon that embodies our brand’s essence. The three interconnected circles symbolize the silver dihydrogen citrate molecule, reflecting the Company’s innovative silver-based antimicrobial technology. Additionally, the design subtly forms the shape of “p,” reinforcing the brand identity of being clean and sophisticated. Click Here

About Branded By Greenville

bbG is a dynamic full-service marketing agency in Greenville, South Carolina, specializing in integrated branding strategies that elevate business and adopt meaningful connections with their audiences. With a strong focus on creativity and innovation, bbG is a creative business partner working with clients to craft compelling brand identities, engaging marketing materials, and impactful digital experiences. bbG’s team of dedicated professionals brings expertise to each project, ensuring a strong brand leading to predictable, profitable advertising and ensuring that every brand transformation aligns with the client’s vision and goals.

About PURE Bioscience, Inc.

PURE focuses on developing and commercializing our proprietary antimicrobial products, primarily in food safety. We provide solutions to combat the health and environmental challenges of pathogens and hygienic control. Our technology platform is based on patented, stabilized ionic silver, and our initial products contain silver dihydrogen citrate, better known as SDC. This broad-spectrum, non-toxic antimicrobial agent formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity, and mitigation of bacterial resistance. PURE’s mailing address is 771 Jamacha Rd. #512, El Cajon, California 92019 (San Diego County area), which serves as its official address for all business requirements. Additional information on PURE is available at www.purebio.com.

Forward-looking Statements: Any statements in this press release that do not describe historical facts may constitute forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Statements in this press release, including quotes from management, concerning the Company’s expectations, plans, business outlook, future performance, future potential revenues, and expected results of the Company’s marketing efforts, the execution of contracts under negotiation, and any other statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are “forward-looking statements.” Forward-looking statements inherently involve risks and uncertainties that could cause our results to differ materially from any forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company’s failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; acceptance of the Company’s current and future products and services in the marketplace, including the Company’s ability to convert successful evaluations and tests for PURE Control and PURE Hard Surface into customer orders and customers continuing to place product orders as expected and to expand their use of the Company’s products; the Company’s ability to maintain relationships with its partners and other counterparties; the Company’s ability to generate sufficient revenues and reduce its operating expenses in order to reach profitability; the Company’s ability to raise the funding required to support its continued operations and the implementation of its business plan; the ability of the Company to develop effective new products and receive required regulatory approvals for such products, including the required data and regulatory approvals required to use its SDC-based technology as a direct food contact processing aid in raw meat processing; competitive factors, including customer acceptance of the Company’s SDC-based products that are typically more expensive than existing treatment chemicals; dependence upon third-party vendors, including to manufacture its products; and other risks detailed in the Company’s periodic report filings with the Securities and Exchange Commission (the SEC), including its Form 10-K for the fiscal year ended July 31, 2024, and Form 8-K for the first quarter ended October 31, 2024. You should not rely on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Jeff Kitchell, Vice President of Operations PURE Bioscience, Inc. Phone: 619-596-8600 Ext. 139